Kelsee, thanks for the reminder of the 20-month BETonMACE milestone Kelsee. As you wrote, it is very hard to guess when the final results will be known. Once the futility analysis comes out, we should be able to narrow down the timeframe but like you wrote it will still be a guess. My guess with current info is September 2017 for hitting 125 events/futility analysis, Q4 2017 for completing the 2400 patient enrollment and Q3 2018 for hitting 250 events/trial completion.

Just to avoid cluttering the board with various replies, I will reply to Koo and Toniv here. 

Toniv, I replied to your Zenith related post on the Zenith hub. Please post Zenith related stuff there in the future and not on the Resverlogix hub.

Koo, I thnk Tada adequately replied to your Hepalink/China post. As Tada pointed out, China has its own path for the regulatory/approval process. I'm no expert in this, so I don't have anything else to add.

BearDownAZ